CLSD - Potencial Short

Potencial Short

News - CLSD-News-Wired News – Clearside BioMedical Reported Positive Top-line Results from Phase-3 Trial Assessing CLS-TA in Macular Edema Associated with Non-infectious Uveitis
Volumen 3.5M, Float 18.42M, Avg Vol (10 day) 3.07M, Avg Vol (3 month) 426.32k, NasdaqGM, Healthcare-Biotechnology
Entry 14.25, Stop Loss 14.90, Take profit 12.50, 1D Still green candle# Entry 1m timeframe#Broke trend line#BreakDown#Stock made in 2 days 130%-News (4 News in 2 days-incredible)
Be ready if market make something unpredictable. Stay with your position, carefully!!!

EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
HE עברית
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out